Related Experiment Video
Updated: Jun 23, 2026

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
Published on: September 19, 2013
The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo
Z Y Yang1, N D Perkins, T Ohno
1Howard Hughes Medical Institute, University of Michigan Medical Center, Department of Internal Medicine, Ann Arbor 48109-0650, USA.
Abstract:
The p21 gene encodes a cyclin-dependent kinase inhibitor that affects cell-cycle progression, but the potential of this gene product to serve as a tumour suppressor in vivo has not been established. In this report, we show that the growth of malignant cells in vitro and in vivo is inhibited by expression of p21. Expression of p21 resulted in an accumulation of cells in G0/G1, altered morphology, and cell differentiation, but apoptosis was not induced. Introduction of p21 with adenoviral vectors into malignant cells completely suppressed their growth in vivo and also reduced the growth of established pre-existing tumours. Gene transfer of p21 may provide a molecular genetic approach to arresting cancer cell growth by committing malignant cells irreversibly to a pathway of terminal differentiation.
Insights
The p21 gene inhibits malignant cell growth and causes differentiation, not apoptosis. Gene transfer of p21 offers a novel approach to halt cancer progression by inducing terminal cell differentiation.
Area of Science:
- Molecular Biology
- Cancer Research
- Cell Biology
Background:
- The p21 gene encodes a cyclin-dependent kinase inhibitor.
- Its role as a tumor suppressor in vivo remains unestablished.
- p21 influences cell-cycle progression.
Purpose of the Study:
- To investigate the in vivo tumor suppressor potential of the p21 gene.
- To determine the effects of p21 expression on malignant cell growth and differentiation.
Main Methods:
- Expression of p21 in malignant cells in vitro and in vivo.
- Utilized adenoviral vectors for gene transfer of p21.
- Monitored cell-cycle progression, morphology, differentiation, and apoptosis.
Main Results:
- p21 expression inhibited malignant cell growth both in vitro and in vivo.
- Accumulation of cells in the G0/G1 phase was observed.
- Altered cell morphology and induced cell differentiation occurred, but apoptosis was not triggered.
- Adenoviral delivery of p21 suppressed existing tumor growth.
Conclusions:
- p21 functions as a tumor suppressor in vivo.
- Gene transfer of p21 represents a potential molecular genetic strategy for cancer therapy.
- p21 may irreversibly commit malignant cells to terminal differentiation, arresting cancer growth.
More Related Videos
11:06Utilization of the Soft Agar Colony Formation Assay to Identify Inhibitors of Tumorigenicity in Breast Cancer Cells
Published on: May 20, 2015
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
Related Concept Videos
Inhibition of Cdk Activity
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...